Featured Research

from universities, journals, and other organizations

Neurologist offers hope to patients with genetic tumor disorder

Date:
July 10, 2014
Source:
Loyola University Health System
Summary:
Although it is rare, tuberous sclerosis complex (TSC) can be a difficult and frightening diagnosis for parents and children. The genetic disorder causes nonmalignant tumors to form in many different organs, including the brain, eyes, kidneys and heart. If a child’s brain is affected by the disease, it can be especially debilitating since it can cause seizures, developmental delays, intellectual disability and autism.

Although it is rare, tuberous sclerosis complex (TSC) can be a difficult and frightening diagnosis for parents and children. The genetic disorder causes nonmalignant tumors to form in many different organs, including the brain, eyes, kidneys and heart. If a child's brain is affected by the disease, it can be especially debilitating since it can cause seizures, developmental delays, intellectual disability and autism.

"TSC is not easily diagnosed because the main symptoms are white spots on the skin that can't be seen by the naked eye and abnormal growth in the heart muscle, which sometimes can be found in an ultrasound during pregnancy," said Nikolas Mata-Machado, MD, pediatric neurologist at Loyola University Health System and assistant professor in the departments of neurology and pediatrics at Loyola University Chicago Stritch School of Medicine.

Because the disease can affect multiple organs, Mata-Machado said it's important for parents to find a center that has a multidisciplinary team.

"It's not just about the brain or heart; it's about how this disease is affects many areas of a child's body. I work with pediatric experts in many medical fields including nephrology, cardiology, pulmonology, hepatology and neuropsychology," Mata-Machado said.

Though there is no cure for TSC, Mata-Machado is one of only a few physicians to use a new drug treatment similar to chemotherapy that causes the tumors to shrink, and offering hope to many patients who do not respond to traditional treatments.

"There are surgical options and also some patients respond well to anti-seizure medications. Unfortunately, I have some patients who do not respond to these medications, some still having up to 40 seizures a day and others are not candidates for surgery. This new treatment gives these patients and their families another chance, a hope," said Mata-Machado.

TSC is a genetic disorder found in 1 of every 25,000 children. It is estimated that 50,000 people in the U.S. are living with the disorder and possibly more because it is difficult to diagnose. The severity of the disease varies greatly, with some patients able to live independent, healthy lives into adulthood.

"It is important for someone with TSC to be monitored by a physician throughout their life as complications can cause serious medical conditions and even death if left untreated," said Mata-Machado. "Still, with advances in medicine and research we are able to offer patients more options for living with this disorder."


Story Source:

The above story is based on materials provided by Loyola University Health System. Note: Materials may be edited for content and length.


Cite This Page:

Loyola University Health System. "Neurologist offers hope to patients with genetic tumor disorder." ScienceDaily. ScienceDaily, 10 July 2014. <www.sciencedaily.com/releases/2014/07/140710111531.htm>.
Loyola University Health System. (2014, July 10). Neurologist offers hope to patients with genetic tumor disorder. ScienceDaily. Retrieved July 29, 2014 from www.sciencedaily.com/releases/2014/07/140710111531.htm
Loyola University Health System. "Neurologist offers hope to patients with genetic tumor disorder." ScienceDaily. www.sciencedaily.com/releases/2014/07/140710111531.htm (accessed July 29, 2014).

Share This




More Health & Medicine News

Tuesday, July 29, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Deadly Ebola Virus Threatens West Africa

Deadly Ebola Virus Threatens West Africa

AP (July 28, 2014) West African nations and international health organizations are working to contain the largest Ebola outbreak in history. It's one of the deadliest diseases known to man, but the CDC says it's unlikely to spread in the U.S. (July 28) Video provided by AP
Powered by NewsLook.com
$15B Deal on Vets' Health Care Reached

$15B Deal on Vets' Health Care Reached

AP (July 28, 2014) A bipartisan deal to improve veterans health care would authorize at least $15 billion in emergency spending to fix a veterans program scandalized by long patient wait times and falsified records. (July 28) Video provided by AP
Powered by NewsLook.com
Two Americans Contract Ebola in Liberia

Two Americans Contract Ebola in Liberia

Reuters - US Online Video (July 28, 2014) Two American aid workers in Liberia test positive for Ebola while working to combat the deadliest outbreak of the virus ever. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Traditional African Dishes Teach Healthy Eating

Traditional African Dishes Teach Healthy Eating

AP (July 28, 2014) Classes are being offered nationwide to encourage African Americans to learn about cooking fresh foods based on traditional African cuisine. The program is trying to combat obesity, heart disease and other ailments often linked to diet. (July 28) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins